BioSig Merges with Streamex, Plans to Raise $1.1 Billion to Advance RWA Tokenization Development

On July 8, BioSig Technologies, a US-based medical device technology company listed on Nasdaq, announced that it has merged with Streamex Exchange Corporation, another Nasdaq-listed company. It also signed a financing agreement of up to $1.1 billion to promote the development of $RWA tokenization business, promote the on-chaining of the $142 trillion commodity market, and focus on gold tokenization.

The company will sell $100 million worth of senior secured convertible bonds and a $1 billion equity credit line. Tether's asset custodian, Cantor Fitzgerald, is the joint lead placement agent for the transaction.

Streamex is a wholly-owned subsidiary of BioSig Technologies, Inc. and is a real-world asset ($RWA) tokenization company focused on the commodity sector. Streamex aims to put the commodity market on-chain and has developed key issuance and trading infrastructure that will revolutionize commodity finance. [BlockBeats]